Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nandini Goel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|October 8, 2024
Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphomaRahul Jain, Taha I Huda, Srijit Paul, et al.
Human Immunology|December 16, 2025
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq filesMadeline C Baker, Srijit Paul, Genesis V Lewis, et al.
Cancer Causes & Control : CCC|December 27, 2025
Higher chemical complementarity of EBV epitopes and IGH CDR3s correlates with better outcomes for lymphoma and ovarian cancerMadeline C Baker, Nandini Goel, Rahul Jain, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 17, 2025
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti-EBV TCR CDR3s: Potential Relevance to Diffuse Large B-Cell LymphomaNandini Goel, Madeline C Baker, Michael T Aboujaoude, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|October 8, 2024
Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphomaRahul Jain, Taha I Huda, Srijit Paul, et al.
Human Immunology|December 16, 2025
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq filesMadeline C Baker, Srijit Paul, Genesis V Lewis, et al.
Cancer Causes & Control : CCC|December 27, 2025
Higher chemical complementarity of EBV epitopes and IGH CDR3s correlates with better outcomes for lymphoma and ovarian cancerMadeline C Baker, Nandini Goel, Rahul Jain, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 17, 2025
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti-EBV TCR CDR3s: Potential Relevance to Diffuse Large B-Cell LymphomaNandini Goel, Madeline C Baker, Michael T Aboujaoude, et al.
Pageof 1